Search

Zai Lab Ltd ADR

Uždarymo kaina

SektoriusSveikatos priežiūra

26.39 2.76

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

25.66

Max

26.63

Pagrindiniai rodikliai

By Trading Economics

Pajamos

191K

-51M

Pardavimai

6.7M

106M

Pelnas, tenkantis vienai akcijai

-0.46

Pelno marža

-47.808

Darbuotojai

1,784

EBITDA

-2.1M

-46M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+53.05% upside

Dividendai

By Acuity

Kitas uždarbis

2026-11-05

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

737M

2.8B

Ankstesnė atidarymo kaina

23.63

Ankstesnė uždarymo kaina

26.39

Naujienos nuotaikos

By Acuity

38%

62%

76 / 339 reitingas Healthcare

Zai Lab Ltd ADR Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-09-21 23:52; UTC

News

Boeing Co. has secured two defense contracts worth $41.5 million, while shares have declined slightly in after-market trading, remaining near the lower end of their one-month range.

2026-09-21 23:51; UTC

News

BlackRock Inc. is trading modestly lower in after-market hours, following the launch of its customizable LifePath Solutions target date framework.

2026-09-21 23:50; UTC

News

Northrop Grumman Corp is trading modestly lower in after-market hours, retracing from a peak and positioned below its 20-day moving average.

2026-09-21 23:36; UTC

Correlated Moves
News

The USD/DKK is trading higher as the People's Bank of China maintained its one-year Loan Prime Rate at 3.00%, signaling stable monetary policy.

2026-09-21 23:31; UTC

News

Tapestry Inc is trading modestly higher in after-market hours, with a current market capitalization of $22.56 billion, following three consecutive lower closes.

2026-09-21 23:25; UTC

News

Pentair PLC declared a $0.27 quarterly dividend amid a class action lawsuit alleging securities fraud, with shares modestly lower in after-market trading.

2026-09-21 23:15; UTC

News

TransDigm Group Inc. announced its Extant Aerospace unit will acquire assets for approximately $240 million, driving the stock higher in after-market hours.

2026-09-21 23:15; UTC

News

Baidu Inc faces two class action lawsuits alleging securities fraud, contributing to a slight decline in after-market trading amid ongoing financial concerns.

2026-09-21 23:11; UTC

Social Media
News

Eli Lilly has started construction on a $6.5 billion facility in Houston to produce its GLP-1 receptor agonist, Foundayo, creating over 600 permanent jobs.

2026-09-21 23:11; UTC

Social Media
News

Intel Corp shares advanced during after-market hours, supported by a record-high Nasdaq close and favorable conditions from falling Treasury yields and oil prices.

2026-09-21 23:06; UTC

News

Weyerhaeuser Co announced a $1 million investment in Drayton Valley, Alberta, marking its first Thrive program initiative in Canada, with shares modestly higher in after-market trading.

2026-09-21 23:06; UTC

News
Correlated Moves

Coinbase Global Inc is launching an IPO allocation service for U.S. customers and ceasing sports wagering in Michigan, with shares trading higher in after-market hours.

2026-09-21 23:06; UTC

News

Ethereum's price has advanced sharply to $2.67K, supported by a broader cryptocurrency rally and increased interest from large holders amid positive regulatory developments.

2026-09-21 23:06; UTC

News

Ethereum's price has advanced sharply to $2.67K, supported by regulatory developments and increased interest from large holders amid a broader cryptocurrency rally.

2026-09-21 23:05; UTC

News

Biogen Inc. is trading slightly higher in after-market hours following approvals for at-home LEQEMBI in Japan and China and new Phase 3 data for EMPAVELI.

2026-09-21 23:02; UTC

News
Social Media

GameStop shares rose in after-hours trading as CEO Ryan Cohen disclosed the purchase of 1.15M shares for about $26.4 million, increasing his ownership to 40.5 million.

2026-09-21 23:02; UTC

News

Bitcoin is sharply higher today, reaching its highest level since January, amid a broader cryptocurrency rally and positive U.S.-China trade developments.

2026-09-21 23:02; UTC

News

Bitcoin surged today to its highest level since January, driven by positive U.S.-China trade developments and easing inflation concerns, despite an earlier pullback.

2026-09-21 23:01; UTC

News

Decline in after-market trading after CMS announces potential fee cuts.

2026-09-21 23:01; UTC

News

Thor Industries shares rose in after-market trading following Keystone RV's record sales at the Hershey RV Show, attributed to strong dealer preparation and customer interest.

2026-09-21 23:01; UTC

News

Salesforce Inc shares are advancing in after-market trading following director David Kirk's acquisition of 4.18k shares for approximately $999.5k.

2026-09-21 23:01; UTC

News
Social Media

Vicor Corporation raised its Q3 2026 growth guidance from nearly 10% to over 20%, driving a sharp rise in its share price during after-hours trading.

2026-09-21 23:01; UTC

News

General Motors Co's stock is higher in after-market trading following a $697.7 million contract modification awarded to GM Defense LLC by the U.S. Department of War.

2026-09-21 23:01; UTC

News

DICK'S Sporting Goods Inc faces class action lawsuits over alleged securities fraud, contributing to a modest decline in after-market trading following disappointing earnings.

2026-09-21 23:01; UTC

Macro News
Correlated Moves
News

The U.S. dollar is consolidating against the yen, currently around JPY156.50, with options worth $2.3 billion expiring today.

2026-09-21 23:00; UTC

News

Endava PLC's shares have declined sharply in after-market trading following the appointment of Conor McShane as Interim CFO amid an accounting investigation.

2026-09-21 22:51; UTC

News
Social Media

Robinhood Markets Inc's stock is trading lower after-hours, reversing from a high of $126.41 earlier in the session amid a recovering cryptocurrency market.

2026-09-21 22:01; UTC

News

In after-market trading, Gartner Inc. has moved higher following five consecutive lower daily closes, despite remaining below its 20-day moving average.

2026-09-21 21:01; UTC

News
Event

AnaptysBio reported Q2 net income of $183.88 million and EPS of $5.11, exceeding expectations, leading to a rise in after-market trading.

2026-09-21 20:12; UTC

News
Correlated Moves

NBT Bancorp Inc. is trading higher in after-market hours following the announcement of Kimberly A. Boynton's appointment to its Board of Directors, effective October 1, 2026.

Akcijų palyginimas

Kainos pokytis

Zai Lab Ltd ADR Prognozė

Kainos tikslas

By TipRanks

53.05% į viršų

12 mėnesių prognozė

Vidutinis 39.333 USD  53.05%

Aukščiausias 45 USD

Žemiausias 36 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Zai Lab Ltd ADR kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

3 ratings

3

Pirkti

0

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

76 / 339 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Zai Lab Ltd ADR

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally administered poly polymerase 1/2 inhibitor; Optune, a cancer therapy that uses electric fields tuned to specific frequencies to kill tumor cells; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; Qinlock to treat gastrointestinal stromal tumors, and VYVGART, a human IgG1 antibody fragment for myesthenia gravis. The company also develops Tumor Treating Fields, a portable device for delivery of electric fields; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Tisotumab vedotin, an antibody drug conjugate; Adagrasib for treating KRAS-G12C-mutated NSCLC, colorectal cancer, and pancreatic cancer; and Bemarituzumab to treat gastric and gastroesophageal junction cancer patients. In addition, it develops Sulbactam/durlobactam, a combination of a beta-lactam antibiotic and a beta-lactamase inhibitor for the treatment of serious infections caused by Acinetobacter; KarXT for the treatment of psychiatric and neurological conditions. It has license and collaboration agreement with Tesaro, Inc. to develop, manufacture, and commercialize niraparib; NovoCure to develop and commercialize Tumor Treating Fields; Deciphera to develop and commercialize ripretinib; Paratek Bermuda Ltd. to develop, manufacture, and commercialize omadacycline; argenx, to develop and commercialize efgartigimod; BMS to develop and commercialize tisotumab vedotin and repotrectinib; Mirati to research, develop, manufacture, and commercialize adagrasib; Amgen to develop and commercialize bemarituzumab; and Innoviva to develop and commercialize Sulbactam-Durlobactam; Karuna to develop and commercialize KarXT; and strategic collaboration with Pfizer for XACDURO. The company was incorporated in 2013 and is headquartered in Shanghai, China.